Loading...
Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression
Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...
Na minha lista:
| Udgivet i: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590435/ https://ncbi.nlm.nih.gov/pubmed/30063256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30198 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|